| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 20, 2005
From the Department of Neurology (A.V., H.C.), CHU Lariboisière, Assistance Publique des Hôpitaux de Paris, France; and Department of Neurology and Clinical Trials Unit (A.V.), Massachusetts General Hospital and Harvard Medical School, Boston.
Background and Purpose--With the advent of modern MRI imaging techniques, cerebral microhemorrhages have been increasingly recognized on gradient-echo (GE) or T2*-weighted MRI sequences in different populations. However, in clinical practice, their diagnostic value, associated risk, and prognostic significance are often unclear. This review summarizes the pathophysiology, differential diagnosis, epidemiology, and clinical significance of cerebral microhemorrhages. Summary of Review--Focal areas of signal loss on GE MRI imaging pathologically represent focal hemosiderin deposition associated with previous hemorrhagic events. Cerebral microhemorrhages have been noted in healthy elderly, ischemic cerebrovascular disease, intracerebral hemorrhage (ICH), cerebral amyloid angiopathy (CAA), and in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Microhemorrhages have been associated with older age, hypertension, smoking, white matter disease, lacunar infarcts, previous ischemic stroke, or ICH. In CAA, microhemorrhages predict both the risk of recurrent lobar ICH and future clinical decline. In patients with ischemic cerebrovascular disease, microhemorrhage number and location may be associated with executive dysfunction and may predict the occurrence of ICH and lacunar infarction. Conclusions--When cerebral microhemorrhages are diagnosed on MRI, conclusions regarding their significance and associated risks should be made based on the population examined. Further studies to characterize the associated risks of cerebral microhemorrhages in different stroke populations are needed to use this new imaging marker in therapeutic decisions.
Revised on November 23, 2005
Accepted on November 25, 2005
Cerebral Microhemorrhage
Anand Viswanathan MD, PhD and Hugues Chabriat MD, PhD
This article has been cited by other articles:
![]() |
S Sveinbjornsdottir, S Sigurdsson, T Aspelund, O Kjartansson, G Eiriksdottir, B Valtysdottir, O L Lopez, M A van Buchem, P V Jonsson, V Gudnason, et al. Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location J. Neurol. Neurosurg. Psychiatry, September 1, 2008; 79(9): 1002 - 1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Vernooij, A. van der Lugt, and M. M.B. Breteler Risk of Thrombolysis-Related Hemorrhage Associated With Microbleed Presence Stroke, July 1, 2008; 39(7): e115 - e115. [Full Text] [PDF] |
||||
![]() |
M. W. Vernooij, A. van der Lugt, M. A. Ikram, P. A. Wielopolski, W. J. Niessen, A. Hofman, G. P. Krestin, and M.M.B. Breteler Prevalence and risk factors of cerebral microbleeds: The Rotterdam Scan Study Neurology, April 1, 2008; 70(14): 1208 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. Mahmud, D. A. Ramsay, S. D. Levin, R. N. Singh, T. Kotylak, and D. D. Fraser Coma With Diffuse White Matter Hemorrhages in Juvenile Diabetic Ketoacidosis Pediatrics, December 1, 2007; 120(6): e1540 - e1546. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Vahedi, M. Boukobza, P. Massin, D. B. Gould, E. Tournier-Lasserve, and M. -G. Bousser Clinical and brain MRI follow-up study of a family with COL4A1 mutation Neurology, October 16, 2007; 69(16): 1564 - 1568. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fiehler, G. W. Albers, J.-M. Boulanger, L. Derex, A. Gass, N. Hjort, J. S. Kim, D. S. Liebeskind, T. Neumann-Haefelin, S. Pedraza, et al. Bleeding Risk Analysis in Stroke Imaging Before ThromboLysis (BRASIL): Pooled Analysis of T2*-Weighted Magnetic Resonance Imaging Data From 570 Patients Stroke, October 1, 2007; 38(10): 2738 - 2744. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Blitstein and G. A. Tung MRI of Cerebral Microhemorrhages Am. J. Roentgenol., September 1, 2007; 189(3): 720 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cordonnier, R. Al-Shahi Salman, and J. Wardlaw Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting Brain, August 1, 2007; 130(8): 1988 - 2003. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Won Seo, B. Hwa Lee, E.-J. Kim, J. Chin, Y. Sun Cho, U. Yoon, and D. L. Na Clinical Significance of Microbleeds in Subcortical Vascular Dementia Stroke, June 1, 2007; 38(6): 1949 - 1951. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Greenberg Intracerebral Hemorrhage: Introduction Stroke, February 1, 2007; 38(2): 746 - 747. [Full Text] [PDF] |
||||
![]() |
A. Srinivasan, M. Goyal, F. A. Azri, and C. Lum State-of-the-Art Imaging of Acute Stroke RadioGraphics, October 1, 2006; 26(suppl_1): S75 - S95. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Viswanathan, J.-P. Guichard, A. Gschwendtner, F. Buffon, R. Cumurcuic, C. Boutron, E. Vicaut, M. Holtmannspotter, C. Pachai, M.-G. Bousser, et al. Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study Brain, September 1, 2006; 129(9): 2375 - 2383. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |